Does Replimune Group (REPL) Have the Potential to Rally 79.61% as Wall Street Analysts Expect?

Core Viewpoint - Replimune Group, Inc. (REPL) has seen a 2.7% increase in share price over the past four weeks, closing at $7.16, with analysts suggesting a potential upside of 79.6% based on a mean price target of $12.86 [1] Price Targets - The average price target consists of seven estimates ranging from a low of $10.00 to a high of $19.00, with a standard deviation of $3.02, indicating variability among analysts [2] - The lowest estimate suggests a 39.7% increase from the current price, while the highest estimate indicates a 165.4% upside [2] Analyst Sentiment - Analysts show strong agreement regarding REPL's ability to exceed previous earnings predictions, which supports the expectation of a stock price increase [4][11] - The Zacks Consensus Estimate for the current year has risen by 5% over the past month, with four estimates increasing and no negative revisions [12] Zacks Rank - REPL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] Caution on Price Targets - While price targets are a common metric, relying solely on them for investment decisions may not be prudent due to historical inaccuracies in predicting stock price movements [3][7][10]